Your browser doesn't support javascript.
loading
Human Milk Oligosaccharides Are Present in Amniotic Fluid and Show Specific Patterns Dependent on Gestational Age.
Jantscher-Krenn, Evelyn; von Schirnding, Lara; Trötzmüller, Martin; Köfeler, Harald; Kurtovic, Una; Fluhr, Herbert; Müller, Andreas; Bagci, Soyhan.
Afiliação
  • Jantscher-Krenn E; Department of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.
  • von Schirnding L; BioTechMed, 8010 Graz, Austria.
  • Trötzmüller M; Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn, D-53113 Bonn, Germany.
  • Köfeler H; Core Facility Mass Spectrometry, Center for Medical Research, Medical University of Graz, 8036 Graz, Austria.
  • Kurtovic U; BioTechMed, 8010 Graz, Austria.
  • Fluhr H; Core Facility Mass Spectrometry, Center for Medical Research, Medical University of Graz, 8036 Graz, Austria.
  • Müller A; Department of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.
  • Bagci S; Department of Obstetrics and Gynecology, Medical University of Graz, 8036 Graz, Austria.
Nutrients ; 14(10)2022 May 14.
Article em En | MEDLINE | ID: mdl-35631205
ABSTRACT
(1)

Background:

Human milk oligosaccharides (HMOs) are already found in maternal circulation in early pregnancy, changing with gestational age. HMOs are also present in cord blood and amniotic fluid (AF). We aimed to assess HMO profiles in AF over the course of gestation. (2)

Methods:

AF was collected during diagnostic amniocentesis, fetal surgery, or C-section from 77 women with a gestational age of ranging from 14.3 to 40.9 weeks. Samples were analysed using high performance liquid chromatography with fluorescence detection. (3)

Results:

We found lactose and up to 16 HMO structures in all AF samples investigated, starting at 14 weeks of gestation. Overall, 3'-sialyllactose (3'SL) and 2'-fucosyllactose (2'FL) were the most abundant HMOs. Individual and total HMO concentrations were significantly positively correlated with gestational age. HMO composition also changed between early, mid- and late pregnancy, with relative concentrations of 3'SL significantly decreasing (44%, 25%, 24%) and 2'FL increasing (7%, 13%, 21%), respectively. (4)

Conclusion:

Our study shows that HMOs are already present in AF early in pregnancy. This demonstrates extensive contact of the fetus with a broad variety of HMOs, suggesting roles for HMOs in fetal tissue development during the time course of pregnancy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Líquido Amniótico / Leite Humano Limite: Female / Humans / Infant / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Líquido Amniótico / Leite Humano Limite: Female / Humans / Infant / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article